MK-677 (10mg)

$103.90

QuantityDiscountPrice
5 - 85%$98.71
9+10%$93.51
FOR LABORATORY RESEARCH USE ONLY.
NOT FOR HUMAN OR ANIMAL CONSUMPTION.
NOT FOR MEDICAL, DIAGNOSTIC, OR VETERINARY USE.

Free shipping on orders over $200!

  • Check Mark Satisfaction Guaranteed
  • Check Mark No Hassle Refunds
  • Check Mark Secure Payments
  • Visa Card
  • MasterCard
  • American Express
  • Discover Card
  • PayPal
  • Apple Pay
GUARANTEED SAFE CHECKOUT
SKU: IN0012 Category:

GH / IGF Research

MK-677 (10 mg)

Non-Peptide Ghrelin Receptor Agonist / Growth Hormone Secretagogue (GHSR-1a)

MK-677 (also known as Ibutamoren) is a potent, orally active, non-peptide agonist of the Growth Hormone Secretagogue Receptor (GHSR-1a) — the same receptor activated by endogenous ghrelin and synthetic GHRP peptides (e.g., GHRP-2, GHRP-6, Hexarelin).

Unlike peptide GH secretagogues, MK-677 is:

  • Orally bioavailable

  • Long-acting (half-life ~24 hours)

  • Capable of producing sustained increases in GH, IGF-1, and IGFBP-3

Because of these properties, MK-677 is widely used for research in:

  • GH/IGF-1 axis physiology

  • Muscle wasting & sarcopenia models

  • Bone density & fracture healing

  • Sleep architecture & circadian GH release

  • Metabolic and appetite-regulation studies

  • Aging, regeneration, and neuroendocrine decline

MK-677 (10 mg) is provided strictly for laboratory research and not for human consumption.


Specifications

Synonyms: MK-677, Ibutamoren, L-163,191, Oratrope
Class: Non-peptide GHSR-1a agonist / GH secretagogue
Molecular Formula: C₂₇H₃₆N₄O₅S
Molecular Weight: ~528.7 g/mol
Presentation: 10 mg research-grade compound (≥98% purity)


Mechanism of Action & Endocrine Signaling

MK-677 binds selectively to GHSR-1a receptors, activating the same intracellular signaling cascade triggered by ghrelin and peptide GHRPs.

1. GHSR-1a activation

Binding stimulates:

  • ↑ IP₃ and intracellular Ca²⁺

  • ↑ PKC activation

  • ↑ GH release from pituitary somatotrophs

  • Inhibition of somatostatin (GH antagonist)

This produces a robust increase in:

  • Growth hormone (GH)

  • Insulin-like growth factor-1 (IGF-1)

  • IGF binding protein-3 (IGFBP-3)

2. Long-acting GH stimulation

Unlike peptides that produce sharp pulses, MK-677 maintains:

  • Sustained GH elevation for ~24 hours

  • Physiologic GH pulsatility (does not override rhythm entirely)

3. Ghrelin-mimetic actions

MK-677 acts on brain ghrelin receptors involved in:

  • Appetite regulation

  • Sleep cycle modulation

  • Energy balance

  • Growth hormone feedback loops


GH/IGF-1 Axis Research Effects

1. Muscle growth & anti-catabolic models

Experimental findings show:

  • Increased lean mass in GH-deficient models

  • Prevention of muscle wasting

  • Enhanced protein synthesis

  • Improved recovery from tissue damage

MK-677 is a major research tool in sarcopenia, cachexia, and aging muscle studies.

2. Bone density & fracture repair

IGF-1 is essential for bone remodeling. MK-677 research demonstrates:

  • Improved bone mineral density (BMD)

  • Accelerated fracture healing

  • Increased osteoblast activity

  • Reduced bone turnover markers associated with aging

3. Sleep architecture and neuroendocrine function

Because GH release is tied to deep sleep, MK-677 is used in studies investigating:

  • Increased REM and slow-wave sleep

  • Enhanced nighttime GH pulses

  • Age-related declines in endogenous GH secretion

4. Metabolic and endocrine modulation

MK-677 research shows:

  • Improved nitrogen retention

  • Reduced inflammatory markers

  • Increased basal metabolic rate

  • Enhanced fatty-acid oxidation


Appetite & Metabolic Regulation Research

As a ghrelin mimetic, MK-677 activates hypothalamic pathways involved in:

  • Appetite stimulation

  • Energy intake and expenditure

  • Glucose homeostasis

  • Insulin sensitivity (effects vary by model)

It is often used to study hunger signaling, energy balance, and endocrine obesity models.


Neuroprotective & Cognitive Research

IGF-1 is essential for brain health; MK-677–induced IGF-1 elevation supports research in:

  • Cognitive decline

  • Neurodegenerative models

  • Motor learning

  • Synaptic plasticity

  • Neurogenesis

MK-677 is also used to investigate neuroendocrine aging and pituitary feedback loops.


Comparison to Peptide GHRPs

PropertyMK-677Peptide GHRPs (Hexarelin, GHRP-2, etc.)
DeliveryOralInjectable
Half-life~24 hrsMinutes
Appetite increaseStrongModerate/variable
GH elevationSustainedPulsatile spike
DesensitizationLowModerate over time

Safety, Limitations & Regulatory Notes

  • MK-677 is not FDA- or EMA-approved for any therapeutic use.

  • Research models report transient increases in appetite, water retention, and fasting glucose—important for study design.

  • Long-term IGF-1 elevation should be monitored in experimental settings.

  • Research-grade MK-677 is not for human or veterinary use and should not be used for bodybuilding, performance, or weight manipulation.


Research Use Only – Important Notice

This MK-677 (10 mg) material is supplied strictly for laboratory research.

  • Not for human consumption

  • Not for therapeutic, cosmetic, or diagnostic purposes

  • For in vitro and controlled animal model experimentation only

  • Descriptions summarize findings from endocrine, metabolic, and neurobiological literature

  • Not to be interpreted as medical or dosing guidance


References (peer-reviewed, non-Wikipedia)

  1. Nass R et al. The GH-releasing effect of MK-677 in healthy adults. J Clin Endocrinol Metab.
    https://pubmed.ncbi.nlm.nih.gov/9467531/

Murphy MG et al. MK-677 increases GH, IGF-1 and fat-free mass. J Clin Endocrinol Metab.
https://pubmed.ncbi.nlm.nih.gov/9079585/

Chapman IM et al. MK-677 improves sleep and GH secretion in elderly subjects. J Clin Endocrinol Metab.
https://pubmed.ncbi.nlm.nih.gov/9645672/

Svensson J et al. Metabolic and body composition effects of MK-677. J Clin Endocrinol Metab.
https://pubmed.ncbi.nlm.nih.gov/10022410/

Smith RG et al. GHSR-1a receptor signaling and ghrelin mimetics. Endocr Rev.
https://pubmed.ncbi.nlm.nih.gov/11588148/